Fertility and Sterility/LinkedIn
Oct 12, 2025, 07:57
Relugolix Combo Therapy in Fibroids and Adenomyosis – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn about a paper by William H. Catherino et al. published in Fertility and Sterility:
“Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: Subgroup analysis of LIBERTY 1 and LIBERTY 2
Title: Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Authors: William H. Catherino, Ayman Al-Hendy, Souhil Zaim, Nadia Bouzegaou, Roberta Venturella, Elizabeth A. Stewart, Rui Wu, Silvia Vannuccini, Julie S. Perry, Viatcheslav G. Rakov, Malcolm G. Munro
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG